{"slideshow_credits": null, "snippet": "An electrical device glued to the scalp can slow cancer growth and prolong survival in people with the deadliest type of brain tumor, glioblastoma, researchers have found.", "abstract": "Researchers report that electrical device glued to scalp can slow cancer growth and prolong survival in people with deadliest type of brain tumor, called glioblastomas; device, produced by British company Novocure, is not cure and on average adds only a few more months of life when paired with standard regimen of surgery, radiation and chemotherapy; findings were presented at meeting of Society for Neuro-Oncology.", "section_name": "Health", "print_page": "26", "document_type": "article", "byline": {"person": [{"firstname": "Denise", "role": "reported", "lastname": "GRADY", "rank": 1, "organization": ""}], "original": "By DENISE GRADY", "contributor": ""}, "web_url": "http://www.nytimes.com/2014/11/16/health/electrical-scalp-device-can-slow-progression-of-deadly-brain-tumors.html", "lead_paragraph": "An electrical device glued to the scalp can slow cancer growth and prolong survival in people with the deadliest type of brain tumor, glioblastoma, researchers have found.", "headline": {"main": "Electrical Scalp Device Can Slow Progression of Deadly Brain Tumors", "print_headline": "Electrical Scalp Device for Deadliest Brain Tumors Can Prolong Survival"}, "_id": "5467598d38f0d87f029cd1ed", "word_count": "1032", "multimedia": [{"height": 126, "url": "images/2014/11/16/us/SUB-BRAIN/SUB-BRAIN-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/11/16/us/SUB-BRAIN/SUB-BRAIN-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 400, "url": "images/2014/11/16/us/SUB-BRAIN/SUB-BRAIN-articleLarge.jpg", "legacy": {"xlarge": "images/2014/11/16/us/SUB-BRAIN/SUB-BRAIN-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/11/16/us/SUB-BRAIN/SUB-BRAIN-thumbStandard.jpg", "legacy": {"thumbnail": "images/2014/11/16/us/SUB-BRAIN/SUB-BRAIN-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-11-16T00:00:00Z", "source": "The New York Times", "news_desk": "National", "keywords": [{"value": "Brain Cancer", "name": "subject", "is_major": "Y", "rank": "1"}, {"value": "Novocure Ltd", "name": "organizations", "is_major": "Y", "rank": "2"}, {"value": "Medical Devices", "name": "subject", "is_major": "Y", "rank": "3"}, {"value": "Cancer", "name": "subject", "is_major": "N", "rank": "4"}, {"value": "Medicine and Health", "name": "subject", "is_major": "N", "rank": "5"}], "blog": [], "subsection_name": null, "type_of_material": "News"}